385 related articles for article (PubMed ID: 36289064)
21. Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
Tan X; Johnson S
Anaerobe; 2019 Dec; 60():102092. PubMed ID: 31472233
[TBL] [Abstract][Full Text] [Related]
22. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
[TBL] [Abstract][Full Text] [Related]
23. A microbial consortium alters intestinal
Rooney AM; Cochrane K; Fedsin S; Yao S; Anwer S; Dehmiwal S; Hota S; Poutanen S; Allen-Vercoe E; Coburn B;
mBio; 2023 Aug; 14(4):e0348222. PubMed ID: 37404011
[TBL] [Abstract][Full Text] [Related]
24. Microbial Interdomain Interactions Delineate the Disruptive Intestinal Homeostasis in Clostridioides difficile Infection.
Herrera G; Arboleda JC; Pérez-Jaramillo JE; Patarroyo MA; Ramírez JD; Muñoz M
Microbiol Spectr; 2022 Oct; 10(5):e0050222. PubMed ID: 36154277
[TBL] [Abstract][Full Text] [Related]
25. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
[TBL] [Abstract][Full Text] [Related]
26. Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention.
Lavoie T; Appaneal HJ; LaPlante KL
Clin Infect Dis; 2023 Dec; 77(Suppl 6):S447-S454. PubMed ID: 38051964
[TBL] [Abstract][Full Text] [Related]
27. Cross-generational bacterial strain transfer to an infant after fecal microbiota transplantation to a pregnant patient: a case report.
Wei S; Jespersen ML; Baunwall SMD; Myers PN; Smith EM; Dahlerup JF; Rasmussen S; Nielsen HB; Licht TR; Bahl MI; Hvas CL
Microbiome; 2022 Nov; 10(1):193. PubMed ID: 36352460
[TBL] [Abstract][Full Text] [Related]
28. Long-term durability and safety of fecal microbiota transplantation for recurrent or refractory Clostridioides difficile infection with or without antibiotic exposure.
Lee CH; Chai J; Hammond K; Jeon SR; Patel Y; Goldeh C; Kim P
Eur J Clin Microbiol Infect Dis; 2019 Sep; 38(9):1731-1735. PubMed ID: 31165961
[TBL] [Abstract][Full Text] [Related]
29. Integrating gut microbiome and host immune markers to understand the pathogenesis of
Ke S; Pollock NR; Wang XW; Chen X; Daugherty K; Lin Q; Xu H; Garey KW; Gonzales-Luna AJ; Kelly CP; Liu YY
Gut Microbes; 2021; 13(1):1-18. PubMed ID: 34132169
[No Abstract] [Full Text] [Related]
30. Rise to the Challenge: Master the Management of Clostridioides difficile Infection.
Voth E; Khanna S
Mayo Clin Proc; 2024 Jun; 99(6):971-979. PubMed ID: 38839189
[TBL] [Abstract][Full Text] [Related]
31. Gut metabolites predict Clostridioides difficile recurrence.
Dawkins JJ; Allegretti JR; Gibson TE; McClure E; Delaney M; Bry L; Gerber GK
Microbiome; 2022 Jun; 10(1):87. PubMed ID: 35681218
[TBL] [Abstract][Full Text] [Related]
32. Faecalibacterium prausnitzii increases following fecal microbiota transplantation in recurrent Clostridioides difficile infection.
Björkqvist O; Rangel I; Serrander L; Magnusson C; Halfvarson J; Norén T; Bergman-Jungeström M
PLoS One; 2021; 16(4):e0249861. PubMed ID: 33836037
[TBL] [Abstract][Full Text] [Related]
33. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
Langdon A; Schwartz DJ; Bulow C; Sun X; Hink T; Reske KA; Jones C; Burnham CD; Dubberke ER; Dantas G;
Genome Med; 2021 Feb; 13(1):28. PubMed ID: 33593430
[TBL] [Abstract][Full Text] [Related]
34. Clinical practice guidelines for Clostridioides (Clostridium) difficile infection and fecal microbiota transplant protocol - recommendations of the Polish Society od Epidemiology and Infectious Diseases.
Piekarska A; Panasiuk A; Stępień PM
Przegl Epidemiol; 2020; 74(1):69-87. PubMed ID: 32500988
[TBL] [Abstract][Full Text] [Related]
35. A Multi-Factorial Observational Study on Sequential Fecal Microbiota Transplant in Patients with Medically Refractory
Monaghan TM; Duggal NA; Rosati E; Griffin R; Hughes J; Roach B; Yang DY; Wang C; Wong K; Saxinger L; Pučić-Baković M; Vučković F; Klicek F; Lauc G; Tighe P; Mullish BH; Blanco JM; McDonald JAK; Marchesi JR; Xue N; Dottorini T; Acharjee A; Franke A; Li Y; Wong GK; Polytarchou C; Yau TO; Christodoulou N; Hatziapostolou M; Wang M; Russell LA; Kao DH
Cells; 2021 Nov; 10(11):. PubMed ID: 34831456
[TBL] [Abstract][Full Text] [Related]
36. Current and future trends in clostridioides (clostridium) difficile infection management.
Khanna S; Gerding DN
Anaerobe; 2019 Aug; 58():95-102. PubMed ID: 31054313
[TBL] [Abstract][Full Text] [Related]
37. Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection.
Haifer C; Paramsothy S; Borody TJ; Clancy A; Leong RW; Kaakoush NO
mSystems; 2021 Feb; 6(1):. PubMed ID: 33531405
[TBL] [Abstract][Full Text] [Related]
38. Navigating changes in
Durham SH; Le P; Cassano AT
J Manag Care Spec Pharm; 2020 Dec; 26(12-a Suppl):S3-S23. PubMed ID: 33533699
[No Abstract] [Full Text] [Related]
39. Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.
Tixier EN; Verheyen E; Luo Y; Grinspan LT; Du CH; Ungaro RC; Walsh S; Grinspan AM
Dig Dis Sci; 2022 Mar; 67(3):978-988. PubMed ID: 33748913
[TBL] [Abstract][Full Text] [Related]
40. Expert opinion on fecal microbiota transplantation for the treatment of
Kumar V; Fischer M
Expert Opin Biol Ther; 2020 Jan; 20(1):73-81. PubMed ID: 31690143
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]